CRASH syndrome: does it teach us about neurotrophic functions of cell adhesion molecules? - PubMed (original) (raw)

Review

CRASH syndrome: does it teach us about neurotrophic functions of cell adhesion molecules?

Ling Zhang. Neuroscientist. 2010 Aug.

Abstract

L1 cell adhesion molecule is a transmembrane glycoprotein of the immunoglobulin superfamily. L1 plays essential roles in normal development of the nervous system, and the mutations in the L1 gene are responsible for CRASH syndrome, a very rare inherited disorder characterized by corpus callosum hypoplasia, mental retardation, adducted thumbs, spastic paraplegia, and hydrocephalus. Here it is hypothesized that in the normal nervous system, the synthesis and neurotrophic function of L1 is controlled by a positive feedback loop, which consists of L1, L1 sheddases, gamma-secretase, L1 extracellular domain (L1ED), L1 cytoplasmic domain (L1CD), and transcriptional factor Pax6. The mutations in L1ED or L1CD will disrupt this feedback loop and inhibit the synthesis and neurotrophic function of L1, therefore contributing to the severe phenotypes in CRASH syndrome. Supported by several lines of experimental evidence, this hypothesis has important implications for the therapy of CRASH syndrome by guiding the development of novel strategies to restore this positive feedback loop to recover the normal function of L1 in CRASH patients.

PubMed Disclaimer

Similar articles

• Induced knockouts provide insights into human L1 syndrome.
  Pielage J. Pielage J. J Exp Med. 2016 Apr 4;213(4):466. doi: 10.1084/jem.2134insight1. J Exp Med. 2016. PMID: 27045055 Free PMC article. Review. No abstract available.
• [X-linked hereditary spastic paraplegia due to mutation in the L1CAM gene: three cases reports of CRASH syndrome].
  Muñoz A, Cabrera-López JC, Santana-Rodríguez A, Toledo-Bravo de Laguna L, Santana-Artiles A, Sebastián-García I. Muñoz A, et al. Rev Neurol. 2016 Mar 1;62(5):218-22. Rev Neurol. 2016. PMID: 26916325 Spanish.
• Three cases with L1 syndrome and two novel mutations in the L1CAM gene.
  Marín R, Ley-Martos M, Gutiérrez G, Rodríguez-Sánchez F, Arroyo D, Mora-López F. Marín R, et al. Eur J Pediatr. 2015 Nov;174(11):1541-4. doi: 10.1007/s00431-015-2560-2. Epub 2015 May 7. Eur J Pediatr. 2015. PMID: 25948108
• Clinical and genetic features of L1 syndrome patients: Definition of two novel mutations.
  Isik E, Onay H, Atik T, Akgun B, Cogulu O, Ozkinay F. Isik E, et al. Clin Neurol Neurosurg. 2018 Sep;172:20-23. doi: 10.1016/j.clineuro.2018.06.007. Epub 2018 Jun 18. Clin Neurol Neurosurg. 2018. PMID: 29960101
• CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1.
  Fransen E, Lemmon V, Van Camp G, Vits L, Coucke P, Willems PJ. Fransen E, et al. Eur J Hum Genet. 1995;3(5):273-84. doi: 10.1159/000472311. Eur J Hum Genet. 1995. PMID: 8556302 Review.

Cited by

• NOG-Derived Peptides Can Restore Neuritogenesis on a CRASH Syndrome Cell Model.
  Gasparotto M, Hernandez Gomez YS, Peterle D, Grinzato A, Zen F, Pontarollo G, Acquasaliente L, Scapin G, Bergantino E, De Filippis V, Filippini F. Gasparotto M, et al. Biomedicines. 2022 Jan 4;10(1):102. doi: 10.3390/biomedicines10010102. Biomedicines. 2022. PMID: 35052783 Free PMC article.
• Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
  Fink JK. Fink JK. Acta Neuropathol. 2013 Sep;126(3):307-28. doi: 10.1007/s00401-013-1115-8. Epub 2013 Jul 30. Acta Neuropathol. 2013. PMID: 23897027 Free PMC article. Review.

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources

• Full Text Sources

  • Atypon